Global Human Albumin Market 2016-2020 with CSL Behring,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Global Human Albumin Market 2016-2020 with CSL Behring, Grifols, Baxalta, Octapharma & Kedrion Dominating

Dublin, July 19, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Human Albumin Market 2016-2020" report to their offering. The analysts forecast the global human albumin market to grow at a CAGR of 4.97% during the period 2016-2020. The report covers the present scenario and the growth prospects of the global human albumin market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic albumin drugs used to treat infections, liver diseases, shock, during surgery, and severe burns. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.

Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period.

A trend helping to propel market growth is the rise in non-therapeutic applications. Non-therapeutic applications of albumin are on a rise. Research is yet to evaluate the applications of albumin as an excipient for commercial use. Some areas where albumin can be employed are as a drug-formulating agent, an ingredient in vaccines and sealant in surgeries, and to coat medical devices and equipment. Though the current supply of albumin for non-therapeutic purposes is low, the high interest shown by the research institutes and pharmaceutical and biopharmaceutical companies in investigating the potential non-therapeutic uses of albumin is expected to drive the market. According to the report, a key driver is the high demand for human albumin in China. China is the largest market for albumin products. Albumin is being used as a volume replacement therapy and for treating kidney diseases, cirrhosis, and cancer. But the demand for plasma products, primarily albumin and immunoglobulins, is outstripping the supply. This is because of the stringent regulations imposed on the supply of raw materials and ban in the import of plasma products. Because of the increased demand for albumin products, the ban on import of plasma products did not include albumin Further, the report states that one challenge that could curtail market growth is the spread of pathogenic contaminants. Key vendors

- CSL Behring - Grifols - Baxalta - Octapharma - Kedrion Other prominent vendors

- AADi - Ablynx - Albumedix - Ampio Pharmaceuticals - Azaya Therapeutics - Beijing Tiantan - Biotest - Bristol-Myers Squibb - Celgene - ConjuChem - GSK - Hebei Changshan Biochem Pharma - HiMedia Laboratories - Hualan Biological Engineering - InVittria - MedxBio - Merck - Mitsubishi Tanabe Pharma - NantBioScience - Novo Nordisk - Novozymes - Shanghai RAAS Blood Products - Sucampo Pharmaceuticals - Teva Pharmaceuticals - Thermo Fisher Scientific - Tianjin SinoBiotech & Beijing Bio-Fortune - Ventria Bioscience - Yoshitomi Pharmaceutical Key Topics Covered: Part 01: Executive summary Part 02: Scope of the report Part 03: Market research methodology Part 04: Introduction Part 05: Plasma therapeutics: An overview Part 06: Global plasma therapeutics market Part 07: Plasma fractionation market Part 08: Albumin: An overview Part 09: Pipeline portfolio Part 10: Global albumin market Part 11: Market landscape Part 12: Market segmentation by application Part 13: Geographical segmentation Part 14: China albumin market Part 15: Market drivers Part 16: Impact of drivers Part 17: Market challenges Part 18: Impact of drivers and challenges Part 19: Market trends Part 20: Vendor landscape Part 21: Appendix

For more information visit http://www.researchandmarkets.com/research/l4...obal_human

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Hematological Drugs

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Linq's $90M Bet on the Infrastructure Behind AI Agents

Updated Category News Views 201

Ninety million dollars just landed on the least glamorous part of the AI-agent rush: the pipes. Linq, the San Francisco private company, announced the round on November 18, 2026, led by Andreessen Horowitz, with returning backing from TQ Ventures, Mucker Capital and Abstract, plus new money from Anthos and Left Lane Capital. Ben Horowitz is joining the board. That is a...

Continue Reading
BreakBio's New CSO Adds Vaccine Trial Credibility in Cancer

Updated Category News Views 27

Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...

Continue Reading
Pickleman’s Chips Turn a Side Into a Brand Signal Now

Updated Category News Views 109

A bag of dill pickle chips is hardly earthshaking news, yet this one says plenty about where fast-casual brands are trying to compete. Pickleman’s Gourmet Cafe is launching its own proprietary chip line with non-GMO ingredients, sunflower oil, a pared-down ingredient profile, and a flavor that actually fits the name on the door. More importantly, a portion of each...

Continue Reading
Eight O'Clock Adds Blonde Roast Pods to Its Lineup

Updated Category News Views 67

A lighter cup of coffee just became Eight O'Clock Coffee's newest swing at the single-serve shelf. On Nov. 19, 2026, the company said it introduced Blonde Roast K-Cup pods, a bright and smooth option aimed at drinkers who prefer a lighter roast. The product is available through Keurig.com and Amazon. That is the whole announcement, and frankly it is better to keep it that...

Continue Reading
OFRM Recall Leaves Investors Facing Hard Questions

Updated Category News Views 22

Nothing wrecks a young consumer brand’s glow faster than a recall involving toddlers, and Once Upon A Farm has just learned that lesson in the ugliest possible way. On November 2, 2026, shares of NYSE:OFRM fell 37% to close at $9.44. That left the stock roughly 47% below its $18 IPO price. Those are not the garden-variety bruises of a weak quarter. That is the market...

Continue Reading
Dental Exams Are Routine Until They Catch Something Early

Updated Category News Views 37

A mouth can look perfectly fine right up until it does not. That is the unglamorous value in the dental exam and X-rays visit described by Dr. Eric Runyon of Smiles Unlimited in Belton, Missouri: it is a structured look for trouble before pain, swelling, or a cracked tooth forces the issue. Nobody throws a parade for preventive care, but waiting for symptoms has a habit...

Continue Reading
Shenzhen Three-Way Summit Puts Stability to the Test

Updated Category News Views 105

Three nuclear powers sharing a room in Shenzhen is the sort of headline that makes every risk desk sit upright, even when the paperwork remains thin. CGTN reports that Chinese President Xi Jinping, Russian President Vladimir Putin and U.S. President Donald Trump met on November 19, 2026, in an unprecedented trilateral summit and issued a Declaration toward Peace. That is...

Continue Reading
Dario's WebMD Deal Opens a Vast, Unproven Channel Path

Updated Category News Views 78

One partnership can look like a gold mine from across the valley; getting the ore out is another matter entirely. DarioHealth has struck a strategic partnership with WebMD Health Services that could put its multi-condition care platform in front of an enormous commercial ecosystem: more than 3,500 employers and 65 million covered lives. That is a meaningful distribution...

Continue Reading
Five Films Put Modern Infrastructure Under a Lens

Updated Category News Views 77

Most infrastructure only earns a thought when it breaks, and that is precisely the nerve these films are trying to touch. Nicely Done Productions has released the final five installments of its ten-part Threads of Connectivity documentary series, hosted on National Geographic's global digital platform. The subjects are illycaffè, Cargill, Honeywell Aerospace, Western...

Continue Reading
Receipts Turns Vegas Party Shirts Into AR Keepsakes

Updated Category News Views 118

A shirt that coughs up a Vegas weekend when scanned is either a smart little keepsake trick or a privacy headache wearing sequins. Receipts™, introduced by Las Vegas-based Naked City Couture and the AR Trading Card Company, is betting it can be the former. The concept is simple enough: friends wear the apparel, capture photos and videos during a trip, upload those...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Wealth Group Holding Limited Successfully Completes $10.8M Offering

Updated Category News Views 79

Top Wealth Group Holding Limited's Successful Public Offering Top Wealth Group Holding Limited (NASDAQ: TWG), a prominent player in the luxury food sector, has recently announced the successful closure of its public offering. The company offered a total of 27 million ordinary shares at a price of $0.40 each, resulting in gross proceeds of approximately $10.8 million...

Continue Reading
BlackRock's Innovative LifePath Paycheck™ Reaches $16B Milestone

Updated Category News Views 619

BlackRock’s LifePath Paycheck™ Achieves Significant Growth Recently, BlackRock announced a significant achievement in the realm of retirement planning. The LifePath Paycheck™, a target-date investment solution designed to provide guaranteed lifetime income, has reached an impressive $16 billion in assets under management (AUM). This innovative strategy is shaping...

Continue Reading
MYR Group to Connect with Investors at Upcoming Conference

Updated Category News Views 139

MYR Group Inc. at D.A. Davidson Conference MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a prominent holding company specializing in electrical contracting, is gearing up to attend the D.A. Davidson 24th Annual Diversified Industrials & Services investor conference. This exciting event allows MYR Group to engage with institutional investors and industry leaders,...

Continue Reading
Regular Dividend Announcement for TDb Split Corp's Equity Shares

Updated Category News Views 267

TDb Split Corp. Announces Monthly Dividend for Shareholders In a recent announcement, TDb Split Corp. has confirmed its monthly distribution for shareholders. For each Class A share, the dividend is set at $0.05000, which translates to an annualized figure of $0.60. Meanwhile, holders of Priority Equity shares will receive $0.05833, or $0.700 on an annual basis. These...

Continue Reading
Exploring Wells Fargo's Recent Options Activity

Updated Category News Views 338

Exploring Wells Fargo's Recent Options Activity Investors with significant resources are displaying a bullish outlook on Wells Fargo (WFC). The actions of these investors could provide valuable insights for retail traders looking to navigate the market effectively. Today, unusual trading patterns emerged in options history, raising curiosity. Although we cannot confirm...

Continue Reading